Floatz logo

Therapeutic Asset Ratings

18,176 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Cyclophosphamide
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
City of Hope Medical CenterP2BB (70)
Cyclophosphamide
Head And Neck Carcinoma
National Cancer Institute (NCI)P2BB (70)
Cyclophosphamide
Oropharyngeal Carcinoma
HRYZ Biotech Co.P2BB (70)
Cyclophosphamide
Ovarian Serous Adenocarcinoma
Roswell Park Cancer InstituteP2BB (70)
Cyclophosphamide
Primary Effusion Lymphoma
National Cancer Institute (NCI)P2BB (70)
Cyclophosphamide
Hairy Cell Leukemia
Kite, A Gilead CompanyP2BB (70)
CYTARABINE
Acute Biphenotypic Leukemia
University of WashingtonP2BB (70)
CYTARABINE
Follicular Lymphoma
GenmabP2BB (70)
DOXORUBICIN
Primary Effusion Lymphoma
National Cancer Institute (NCI)P2BB (70)
ETOPOSIDE
Nodal Marginal Zone B-Cell Lymphoma
University of California, DavisP2BB (70)
Fludarabine
Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI)P2BB (70)
Fludarabine
Angioimmunoblastic T-Cell Lymphoma
National Cancer Institute (NCI)P2BB (70)
Fludarabine
MALT Lymphoma
UNC Lineberger Comprehensive Cancer CenterP2BB (70)
Fludarabine
Nodal Marginal Zone B-Cell Lymphoma
UNC Lineberger Comprehensive Cancer CenterP2BB (70)
Fludarabine
Marginal Zone Lymphoma
Paolo Caimi, MDP2BB (70)
Golcadomide
Diffuse Large B-Cell Lymphoma
Fondazione Italiana Linfomi - ETSP2BB (70)
Irinotecan
Anaplastic Oligodendroglioma
City of Hope Medical CenterP2BB (70)
Irinotecan
Head And Neck Squamous Cell Carcinoma
Neonc Technologies, Inc.P2BB (70)
LENALIDOMIDE
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P2BB (70)
LENALIDOMIDE
Mycosis Fungoides
City of Hope Medical CenterP2BB (70)
METHOTREXATE
Leukemia, Myeloid, Accelerated-Phase
University of Michigan Rogel Cancer CenterP2BB (70)
METHOTREXATE
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
University of Michigan Rogel Cancer CenterP2BB (70)
Nilotinib
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
The University of Hong KongP2BB (70)
Olaparib
Malignant Pancreatic Neoplasm
MOMA TherapeuticsP2BB (70)
Plerixafor
Hodgkins Lymphoma
Thomas Jefferson UniversityP2BB (70)
Showing 1251 to 1275 of 18,176 assets
PreviousPage 51 of 728Next